Brain Startup Synchron Says AI Will Be Instrumental for Devices
Medical device maker has integrated OpenAI’s latest AI model into its technology.
Tom Oxley, chief executive officer of Synchron Inc.
Photographer: David Paul Morris/BloombergBrain-computer startup Synchron Inc. is tapping OpenAI’s latest artificial intelligence models to help paralyzed patients communicate using its implant — a still-early combination of hardware and AI that Synchron’s chief executive officer said could eventually be transformational for patients.
New York-based Synchron, a competitor to Elon Musk’s brain startup Neuralink Corp., implants its device into the brain via a vein in the neck. Once active, the implant can communicate a patient’s desired actions to a tablet computer. The device, called the Stentrode, can also help patients with tasks like writing emails or answering texts.